BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX, Inc. has announced an agreement with GenomOncology, Inc. to co-market Archer’s NGS assays and GenomOncology’s data interpretation software for somatic mutation detection and reporting.
For more information, please visit
http://www.businesswire.com/news/home/20[...]rate-NGS-Workflow-Applications